Offres d'emploi
Trouvez des postes près de chez vous, sur site, hybrides ou à distance.- Emplois similaires à : Facilities Manager - Cannock
Facilities Manager - Oxford
ImmunocoreShipton
Facilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreMollingtonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreBarchestonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreCheddingtonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreWasingFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreSlaptonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreOakhillFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreStretton on FosseFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreShenley Brook EndFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreDraycot FoliatFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreFroxfieldFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreOxhillFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreLoughtonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreMaidenheadFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreBurghclereFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreTredingtonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreEast WoodhayFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreGreat BrickhillFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreAdstoneFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreHintonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreByfieldFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreSimpsonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreSeer GreenFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreBarkhamFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreGreat BedwynFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
